We also show here that whereas PMCA4 abundance is associated with longer relapse-free patient survival in luminal LUMA (grade 2) and LUMB1 breast cancer subtypes, the opposite is observed for patients with HER2 positive LUMB2 breast cancer (Fig. 1d). Here, ERBB2 is linked to breast cancer.